

![]() |
Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells |
|
Authors | ![]() | |
Published in | Transplantation. 2003, vol. 76, no. 5, p. 838-43 | |
Abstract | The innate immune system, including complement and natural killer (NK) cells, plays a critical role in activation and damage of endothelial cells (ECs) during xenograft rejection. The semisynthetic proteoglycan analog dextran sulfate (DXS, molecular weight 5,000) is known to inhibit the complement and coagulation cascades. We hypothesized that DXS may act as an "EC-protectant" preventing complement and NK lysis by functionally replacing heparan sulfate proteoglycans that are shed from the EC surface on activation of the endothelium. | |
Keywords | Animals — Anticoagulants/metabolism/pharmacology — Aorta/cytology — Blood Proteins/pharmacology — Cells, Cultured — Complement Activation/drug effects — Complement Inactivator Proteins/pharmacology — Dextran Sulfate/metabolism/pharmacology — Dose-Response Relationship, Drug — Endothelium, Vascular/cytology/drug effects/immunology — Graft Rejection/drug therapy/immunology — Heparin Lyase/pharmacology — Humans — Killer Cells, Natural/drug effects/immunology — Swine — Transplantation, Heterologous/immunology | |
Identifiers | PMID: 14501864 | |
Full text | ||
Citation (ISO format) | LAUMONIER, Thomas et al. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells. In: Transplantation, 2003, vol. 76, n° 5, p. 838-43. doi: 10.1097/01.TP.0000078898.28399.0A https://archive-ouverte.unige.ch/unige:40448 |